Progressive sight loss requires specialist assessment Experimental peptide claims should not delay review by an ophthalmologist or access to established genetic, retinal and low-vision services
Regulatory status varies between countries, and researchers should ensure compliance with applicable laws, institutional policies, and research governance requirements before acquiring or handling research materials
Mikus D, Sikiric P, Seiwerth S, et al
TB-500 Maintenance Phase Dose How long: Weeks 5 to 12 (or weeks 7 to 12 if you ran the 6-week loading phase) Dose: 2 mg subcutaneous, once a week Some people taper to 2 mg every two weeks toward the end of the cycle, especially for acute injuries that are clearly improving by week 6
Pen / Pre-mixed Reference Format Pre-mixed vial Concentration 100 mg/mL Dose example 50 mg Volume per dose 0.50 mL (50 units) Format Pre-mixed vial Concentration 100 mg/mL Dose example 100 mg Volume per dose 1.00 mL (100 units) Format Pre-mixed vial (high-conc.) Concentration 200 mg/mL Dose example 100 mg Volume per dose 0.50 mL (50 units) Format Pen device Concentration Set per device Dose example Click-set per dose Volume per dose Per device label Always verify label concentration and pharmacy beyond-use dating
Keeps the needle well away from the sciatic nerve
